Back to the solutions

Smart liquid biopsy panels with selected key genes per tumor type

Order an OncoSELECT

I am a patient

See how our solutions can help you in the treatment of cancer.

See case reports

OncoSELECT Solution

OncoSELECT is a fast, minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colon and, breast (ER+ or HER2+) cancer patients.
It is the perfect tool to identify therapeutic solutions for cancer patients not able to get their tumor biopsied, to monitor the progression evolution of their cancer and to detect treatment resistance as soon as it appears.

 

Description

Following a recent change in FDA guidelines, a liquid biopsy is now approved as the first diagnostic tool for non-small cell lung cancer patients. OncoSELECT is the perfect test to do a first screening of the most relevant genes related to treatments.

OncoSELECT targets more than 100 resistance mutations and sensitivity to targeted therapies (SNVs,indels, translocation and CNVs) as well as specific genes selected for each cancer type.

Download the product sheet

Download the genes panel

Advantages

To select a therapy : Mainly for patients whose tissue sample is not available or is limited, when it is challenging or not possible to perform a biopsy of the primary tumor or of any metastases, or if the biopsy sample is too old.

As a monitoring tool : It is the right way to monitor tumor response to the treatment, detect potential resistance, adapt the treatment and, by doing so, extend the patient’s life. It is fast, minimally invasive for the patient and more sensitive than routine imaging.

 

Logistics

Turnaround time for OncoSELECT is 7 working days. Just send us a blood sample (2 Streck tubes each containing 10 ml).

Download sample prep protocol

 

 

How much does OncoSELECT cost?

Suggested price

1290 EUR

Country-specific price differences

The price indicated here is the recommended retail price. It can, however, This price might vary from one in your country to another, depending on different factors like importation fees, freight costs, currency exchange rates, …
For more info or to order this product in your region, please contact our local representative.

Reimbursement statement

Our tests are currently reimbursed in a growing number of countries. In the United Kingdom, OncoSTRAT&GO is reimbursed for patients insured by BUPA Global Insurance, using code 7331B. Other countries, like Spain, Chili, South Africa and Poland, also cover the cost of our tests, either totally or partially. Don’t hesitate to contact us for more information.

How can I get OncoSELECT?

Ordering a solution is very simple: just log into OncoSHARE, and select your solution(s). If you don’t have a kit, we’ll send you one. After interpretation by our expert team thean interactive report iswill be available for you on OncoSHARE. You can review, edit and/or share it.

See more about OncoSHARE

Order an OncoTRACE
The case report

Alicia, 49 years old when diagnosed

Was given the OncoDEEP solution following a stage 3 lung cancer.

View Alicia's report